Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Combination therapy is more effective for prostate volumes over 60 ml.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

The "Stimufit" tincture is safe and effective for treating hair loss.

Ozonated olive oil may effectively treat fungal skin infections.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Topical 1% pimecrolimus effectively treated alopecia areata.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Etanercept effectively treated a severe skin condition when other treatments failed.

ZO-1 helps hair follicle stem cells renew better by changing their structure.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

The drug combination significantly reduced epileptic drop attacks in patients.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

MK-386 reduces sebum DHT levels.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.